Inside Cambridge's Ray Dolby Centre where history could be made
The Ray Dolby Centre is as different to the original Cavendish Laboratory as a building can be. Canopies covered in copper fish scales hang above the staircases and exhibits of famous instruments are displayed in glass cases. Away from the entrance lies a warren of 173 laboratories. In many, the air is constantly filtered, light is controlled and there is no vibration.
These controls are vital to the experiments now conducted here, but Dr Dave Ellis, head of nanofabrication, says those sensitivities also made moving the laboratory much harder."Some equipment, like the optics tables, can't be tilted at all, so there were rough patches of road which we had to resurface to make the journey smooth," he says. "The removals company also developed new techniques to ensure the lorries stayed stable when the equipment was moved. "Everyone went to great lengths to make it a success."
In one of the new labs, PHD student Sarah Sibug-Torres is trying to develop a toilet that uses gold and lasers to analyse urine - a process called Surface-enhanced Raman spectroscopy. "Everyone uses a loo," says Ms Sibug-Torres, "but not everyone realises the urine we flush away contains thousands of different types of molecules."[They] can give clues about whether someone is developing disease or responding to medication, for example. "Each type of molecule vibrates in a different way, so, unlike with a traditional urine dip test, we can identify these molecules even in very low concentrations."Ms Sibug-Torres hopes her work will enable early diagnosis and better all-round health in future.
Other teams at the Cavendish are working on ways to use light to improve endoscopic tests for oesophageal cancer.They are also creating components to help the CERN Collider in Switzerland, which aims to detect new particles furthering our understanding of dark matter in space. Dr Stefan Diesing is developing new solar panels to power the satellites that we rely on in space for GPS, communication and earth monitoring."In space, unlike on earth, there's no magnetic field to shield you against all the things that are whizzing around," he explains. "Those particles can damage the solar panels, so they don't last as long. "We're developing a much more resilient material which is also very thin."Dr Diesing says these new panels could one day enable solar farms in space, which capture energy and beam it back for use on earth.
The building has been designed so research teams collaborate more and share ideas. The head of the Cavendish Laboratory, Prof Mete Atatüre, says interaction is critical but it was much harder in the old building."I loved the old lab, but it prioritised lab space over everything else," she explains."Here, you bump into people all the time and discuss your work - and that can lead to something else."While some features are deliberately different to the previous lab, others protect tradition. In the coming weeks, some of the old blackboards will be installed. Prof Atatüre insists it is important that scientists still work through problems by "getting chalk on their hands", much like their predecessors.
In addition to funding from the University of Cambridge, the Ray Dolby Foundation gave £85m to the project. Ray Dolby was a PHD student in Cambridge in the 1950s and went on to invent the world famous surround-sound system that transformed music and movies from the late 1970s. The government has also provided £75m to keep the building as a national resource open to scientists from across the UK.It is also expected to inspire both students and the public alike.With the Cavendish Laboratory being home to 31 Nobel Prize winners, it is hoped this new facility will soon have a few history-makers of its own.
Follow Cambridgeshire news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
20 minutes ago
- The Independent
Foreign aid cuts could lead to millions more dying from superbug infections by 2050, study warns
The growing global health crisis of superbug infections could undo decades of progress in medicine, according to a new report, which warns that foreign aid cuts could lead to millions more dying worldwide by 2050. Without collective global action, growing cases of infections caused by such antimicrobial-resistant (AMR) microbes could cost the global economy nearly $2trillion, the UK government-funded research says. The research forecasts the future impact of AMR on global economies under different scenarios of interventions across regions, income groups, and countries. Bacteria have been evolving resistance to the antibiotics used by doctors to kill them in recent years, causing even what used to be the simplest-to-treat infections to become potentially life-threatening. With scientists locked in a race to create and improve access to a 'new generation' of drugs capable of defeating even the most resistant of such superbugs, global research funding cuts risk stalling progress. If the superbug spread continued at the same trend as seen since 1990 in a 'business-as-usual' scenario, it could lead to nearly 39 million deaths between 2025 and 2050, a growing body of studies suggests. However, if there is improved access to antibiotics against such bacterial infections, it could avert 90 million deaths over this period, the latest report estimates. Better access to antibiotics could lead to a $19bn annual reduction in healthcare costs by 2050, they say. 'This scenario would increase global GDP by $269bn over the business-as-usual scenario. The health benefits from this intervention would be worth half a billion dollars if disability-adjusted life years are valued at the GDP per capita of a given country,' scientists noted. In comparison, the worst-case scenario of an accelerated rise in AMR at the rate of the bottom 15 per cent of countries could lead to an additional 6.7 million people dying from infections, they warn. The report comes following the UK government's Thursday announcement that it was axing the Fleming Fund – a major £265m British programme combating AMR in developing countries. 'Without effective interventions, health care costs could increase by $176bn per year by 2050, and global output could be $1.7trillion lower than in the business-as-usual scenario,' the report noted. Previous research suggests that combating superbugs would require 6 to 15 new drugs developed for treatment per decade. Scientists estimate this could require an annual additional research and development cost of $2.2bn. 'If all high-income countries funded this research and development in proportion to their GDP, it would cost them 0.0036 per cent of GDP in 2025,' they wrote. 'For these new drugs to provide the promised health benefits, people across the world must have access to them. We estimate that it would cost $59bn to ensure that all countries have outcomes for bacterial infections that match the quality of treatment currently available in the 85th percentile of countries,' researchers noted. Considering these economic and health benefits, scientists say there would be 'excellent value for money' offered by these global interventions.
The Independent
20 minutes ago
- The Independent
Bluetongue has been detected in England. Here's what you should know
A tiny midge, no bigger than a pinhead, is bringing UK farming to its knees. The culprit? A strain of the bluetongue virus that's never been seen before. As of July 1, the whole of England has been classed as an 'infected area' due to bluetongue virus serotype 3 (BTV-3). There are movement restrictions and testing in place in Scotland, Wales and the island of Ireland. No animals from England – or that have passed through England – are allowed to attend this year's Royal Welsh Show on July 21-24, for example. The virus, which causes illness and death in sheep, cattle, goats and other ruminants, is spread by biting midges. Although it poses no risk to humans and can't be transmitted from one animal to another, the latest outbreak is more severe than previous ones. And it could cause lasting damage to UK farming. Bluetongue isn't new to the UK, however. A different strain, BTV-8 was detected in 2007 and contained. But BTV-3 is a different story. First detected in the Netherlands in late 2023, it was quickly spotted in the UK, where an early containment effort initially appeared successful. But the virus made a comeback in autumn 2024 – and this time it spread. On its second attempt, the virus was able to circulate and caused an outbreak. With little existing immunity, BTV-3 has now established itself, prompting concerns about animal welfare, food production and farming livelihoods. What does the disease do? Sheep tend to be the most severely affected, though all ruminants are at risk. Clinical signs are species-specific but can include swelling of the face, congestion, nasal discharge, ulcers in the mouth and nose, difficulty breathing and abortion or birth deformities. Bluetongue can cause the animal's tongue to swell. It can also turn blue from a lack of blood flow – although this is somewhat rare. Bluetongue disease causes suffering in animals, and while there is a vaccine, there is no treatment for the disease once it's contracted. BTV-3 appears to be more lethal than earlier strains. In the Netherlands, vets report that BTV-3 is causing more severe symptoms than BTV-8 did. Vets in England reported that in some herds 25-40% of cows failed to get pregnant, and there was a high rate of birth defects and stillborn calves. One farm in Suffolk started the calving season with 25% of their cows not pregnant and ended with just 48 calves from 97 cows. Belgium has seen a fall in calf births, reduced milk deliveries and higher mortality in small ruminants compared to the previous three years. How is it spread? Bluetongue virus is transmitted by midges from the Culicoides genus. These are tiny, biting insects that thrive in mild, wet conditions. Multiple midges can bite the same animal, and it only takes one of them to carry BTV before that animal becomes a host for further transmission. When animals are transported long distances, infected individuals can be bitten again and introduce the virus to previously uninfected midge populations. Climate change is making outbreaks like this more likely. Milder winters and cooler, wetter summers are ideal for midges, increasing both their numbers and their biting activity. While there's no danger to human health, the consequences of BTV-3 are far-reaching. Limitations on movement, exports and imports are being imposed to help prevent the spread of the disease, but this could also hamper farming practices and trade. The disease and its associated restrictions pose another source of stress for farmers, 95% of whom have ranked mental health as the biggest hidden problem in farming. Genetic pick and mix One of the reasons bluetongue is so tricky to manage is its ability to evolve. It has a segmented genome, meaning its genetic material, in this case RNA, is split into ten segments. This characteristic is exclusive to 'reassortment viruses' and means that they can easily exchange segments of RNA. It's like a genetic pick and mix with ten different types of sweets that come in an unlimited number of flavours. This allows BTV to create new, genetically distinct 'serotypes', which may have a selective advantage or a disadvantage. Those with an advantage will emerge and spread successfully, while those with a disadvantage will not emerge at all. This process, known as 'reassortment', is partly responsible for the numerous influenza pandemics throughout history and has even allowed diseases to jump the species barrier. Although bluetongue doesn't affect humans directly, its spread poses a growing threat to the UK's livestock sector and food supply. It's important to learn from other countries that are further along in the BTV-3 outbreak so that the likely effects can be anticipated in the UK.
The Guardian
an hour ago
- The Guardian
Is it true that … cracking your knuckles causes arthritis?
'This is a common question I get asked over the dinner table,' says Kimme Hyrich, a rheumatologist and professor of epidemiology at the University of Manchester. And it's no wonder – as many as 54% of us are habitual knuckle crackers, regularly making those distinctive popping noises as we manipulate the joints. 'The knuckle joint is a very tight space and there's a little bit of fluid in it. When people crack their knuckles, they very temporarily enlarge the space,' says Hyrich. 'The pressure drops and gas that's dissolved in that fluid forms bubbles – and it's the bursting of those bubbles that causes the sound.' The type of arthritis people tend to worry about is osteoarthritis – the most common form. It's a painful condition that causes swelling and stiffness in the joints, and becomes more common as we age. 'We don't fully understand the cause,' Hyrich says, 'but genetics play a large role. Joint trauma is also a risk factor.' It's probably this association with injury that fuels concerns about knuckle-cracking. 'People are likely worried they're damaging the joint,' she says. But is there any actual harm? According to Hyrich, the evidence says no. 'Researchers have looked at people with and without arthritis and asked whether they cracked their knuckles – there's been no difference. Others have compared people who do and don't crack their knuckles using X-rays – again, no difference.' Perhaps the most famous example is a US physician who, in an effort to prove his mother wrong, cracked the knuckles on just one hand every day for over 60 years. When he finally had both hands assessed, there were no signs of arthritis in either. So what kinds of trauma do increase your risk of osteoarthritis? 'Sporting injuries,' Hyrich says, 'such as breaking a bone near your joint, or tearing ligaments.' People who already have another kind of arthritis, such as the autoimmune condition rheumatoid arthritis, are also more prone to osteoarthritis. Her best advice for avoiding it? 'Maintain a healthy lifestyle, stay active, and keep to a healthy weight.'
